Literature DB >> 32478399

Denosumab for Fibrous Dysplasia: Promising, but Questions Remain.

Michael T Collins1, Luis Fernandez de Castro1, Alison M Boyce1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32478399      PMCID： PMC7497813          DOI： 10.1210/clinem/dgaa091

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

1.  Denosumab treatment for fibrous dysplasia.

Authors:  Alison M Boyce; William H Chong; Jack Yao; Rachel I Gafni; Marilyn H Kelly; Christine E Chamberlain; Carol Bassim; Natasha Cherman; Michelle Ellsworth; Josephine Z Kasa-Vubu; Frances A Farley; Alfredo A Molinolo; Nisan Bhattacharyya; Michael T Collins
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

2.  First in Mice: RANKL Neutralization in Fibrous Dysplasia.

Authors:  Luis F de Castro PhD; Alison M Boyce Md; Michael T Collins Md
Journal:  J Bone Miner Res       Date:  2019-11-07       Impact factor: 6.741

3.  Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.

Authors:  Luis F de Castro; Andrea B Burke; Howard D Wang; Jeffrey Tsai; Pablo Florenzano; Kristen S Pan; Nisan Bhattacharyya; Alison M Boyce; Rachel I Gafni; Alfredo A Molinolo; Pamela G Robey; Michael T Collins
Journal:  J Bone Miner Res       Date:  2018-11-29       Impact factor: 6.741

4.  Denosumab in Patients With Fibrous Dysplasia Previously Treated With Bisphosphonates.

Authors:  Bas C J Majoor; Socrates E Papapoulos; P D Sander Dijkstra; Marta Fiocco; Neveen A T Hamdy; Natasha M Appelman-Dijkstra
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

5.  Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone.

Authors:  Pablo Florenzano; Kristen S Pan; Sydney M Brown; Scott M Paul; Harvey Kushner; Lori C Guthrie; Luis Fernandez de Castro; Michael T Collins; Alison M Boyce
Journal:  J Bone Miner Res       Date:  2019-01-15       Impact factor: 6.741

6.  Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells.

Authors:  P Bianco; S A Kuznetsov; M Riminucci; L W Fisher; A M Spiegel; P G Robey
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  RANKL Inhibition in Fibrous Dysplasia of Bone: A Preclinical Study in a Mouse Model of the Human Disease.

Authors:  Biagio Palmisano; Emanuela Spica; Cristina Remoli; Rossella Labella; Annamaria Di Filippo; Samantha Donsante; Fabiano Bini; Domenico Raimondo; Franco Marinozzi; Alan Boyde; Pamela Robey; Alessandro Corsi; Mara Riminucci
Journal:  J Bone Miner Res       Date:  2019-08-21       Impact factor: 6.390
  7 in total
  1 in total

Review 1.  Denosumab Treatment for Giant Cell Tumors, Aneurysmal Bone Cysts, and Fibrous Dysplasia-Risks and Benefits.

Authors:  Kristen S Pan; Alison M Boyce
Journal:  Curr Osteoporos Rep       Date:  2021-02-22       Impact factor: 5.163
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.